The use of alternative medical therapies in patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 43, Issue 6, 2000, Pages 1410-1418

  Moore, Andrew D ^a   Petri, Michelle A ^b   Manzi, Susan ^c   Isenberg, David A ^d   Gordon, Caroline ^e   Senécal, Jean Luc ^f   Pierre, Yvan S T ^a   Joseph, Lawrence ^a   Penrod, John ^a   Fortin, Paul R ^a   Sutcliffe, Nurhan ^d   Goulet, Jean Richard ^f   Choquette, Denis ^f   Grodzicky, Tamara ^f   Esdaile, John M ^g   Clarke, Ann E ^a,h  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f NOTRE DAME HOSPITAL   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUPUNCTURE; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; COHORT ANALYSIS; COST BENEFIT ANALYSIS; FEEDBACK SYSTEM; FEMALE; HERBAL MEDICINE; HUMAN; HYPNOSIS; IMAGERY; MAJOR CLINICAL STUDY; MALE; MANIPULATIVE MEDICINE; MASSAGE; PRIORITY JOURNAL; REIMBURSEMENT; RELAXATION TRAINING; SATISFACTION; SELF HELP; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 18844481708     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200006)43:6<1410::AID-ANR27>3.0.CO;2-U     Document Type: Article

References (48)

1. Panush RS, for the Complementary and Alternative Therapies Subcommittee of the Communications and Marketing Committee. American College of Rheumatology position statement: "complementary" and "alternative" therapies for rheumatic diseases. Atlanta: American College of Rheumatology; 1998.
2. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-52.
3. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-75.
4. Goldbeck-Wood S, Dorozynski A, Lie LG, Yamauchi M, Zinn C, Josefson D, et al. Complementary medicine is booming worldwide. BMJ 1996;313:131-3.
5. Fisher P, Ward A. Complementary medicine in Europe. BMJ 1994;309:107-11.
6. Millar WJ. Use of alternative health care practitioners by Canadians. Can J Public Health 1997;88:154-8.
7. Kronenfeld JJ, Wasner C. The use of unorthodox therapies and marginal practitioners. Soc Sci Med 1982;16:1119-25.
8. Boisset M, Fitzcharles M-A. Alternative medicine use by rheumatology patients in a universal health care setting. J Rheumatol 1994;21:148-52.
9. Fitzcharles M-A, Esdaile JM. Nonphysician practitioner treatments and fibromyalgia syndrome. J Rheumatol 1997;24:937-40.
10. Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney WM, Weinberger M. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 1999;131:409-16.
11. Ramos-Remus C, Gamez-Nava JI, Gonzalez-Lopez L, Suarez-Almazor ME. Use of alternative medicine in a consecutive sample of patients with systemic lupus erythematosus [letter]. J Rheumatol 1997;24:12.
12. Pelletier KR, Marie A, Krasner M, Haskell WL. Current trends in the integration and reimbursement of complementary and alternative medicine by managed care, insurance carriers, and hospital providers. Am J Health Promot 1997;12:112-23.
13. Panush RS. Reflections on unproven remedies. Rheum Dis Clin North Am 1993;19:201-6.
14. Yocum DE, Hodes R, Sundstrom WR, Cleeland CS. Use of biofeedback training in treatment of Raynaud's disease and phenomenon. J Rheumatol 1985;12:90-3.
15. Deal CL, Moskowitz RW. Nutraccuticals as therapeutic agents in osteoarthritis: the role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999;25:379-95.
16. Paramore LC. Use of alternative therapies: estimates from the 1994 Robert Wood Johnson Foundation National Access to Care survey. J Pain Symptom Manage 1997;13:83-9.
17. Biais R, Maïga A, Aboubacar A. How different are users and non-users of alternative medicine? Can J Public Health 1997;88:159-62.
18. Carey TS, Garrett J, Jackman A, McLaughlin C, Fryer J, Smucker DR, et al. The outcomes and costs of care for acute low back pain among patients seen by primary care practitioners, chiropractors, and orthopedic surgeons. N Engl J Med 1995;333:913-7.
19. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socioeconomic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology 1999;38:1130-7.
20. Sutcliffe N, Clarke AE, Levinton C, Frost C, Gordon C, Isenberg DA. Associates of health status in patients with SLE. J Rheumatol 1999;26:2352-6.
21. Clarke AE, Petri MA, Manzi S, Isenberg DA, Gordon C, Senecal J-L, et al. An international perspective on the well-being and health care costs for patients with systemic lupus erythematosus. J Rheumatol 1999;26:1500-11.
22. St. Pierre Y, Penrod J, Petri M, Manzi S, Isenberg DA, Gordon C, et al. Underestimating the value of rheumatic diseases: assessing the indirect costs of women with lupus (SLE) [abstract]. Arthritis Rheum 1998;41 Suppl 9:S221.
23. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
24. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
25. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
26. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
27. Cohen S, Mermelstein R, Kamarck T, Hoberman HM. Measuring the functional components of social support. In: Sarason IG, Sarason BR, editors. Social support: theory, research, and applications. The Hague: Martinus Nijhoff; 1985. p. 73-94.
28. Ware JE Jr, Sherbourne CD. The MOS 36 item Short-Form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
29. Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA, et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997;24:1608-14.
30. Fortin PR, Abrahamowicz M, Neville C, Du Berger R, Fraenkel L, Clarke AE, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998;7:101-7.
31. Ware JE Jr, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute, New England Medical Center; 1994.
32. Ware JE Jr, Snyder MK, Wright R, Davies AR. Defining and measuring patient satisfaction with medical care. Eval Program Plan 1983;6:247-63.
33. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
34. Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum 1993;36:1548-59.
35. Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Q 1982;60:429-62.
36. Gronau R. Home production - a survey. In: Ashenfelter OC, Layard R, editors. Handbook of labor economics. Amsterdam: North Holland; 1986. p. 273-304.
37. Statistics Canada. Earnings of men and women, 1995. Cat. no.: 13-217. Ottawa: Statistics Canada; 1997.
38. Ministry of Industry. Households' unpaid work: measurement and valuation. Cat. no.:13-603E. Ottawa: Statistics Canada; 1995.
39. Jackson C. The value of household work in Canada, 1986. Cat. no.:11-010. Ottawa: Statistics Canada, Ministry of Industry; 1992.
40. Raftery AE. Bayesian model selection in social research. Sociol Method 1995;25:111-63.
41. Visser GJ, Peters L, Rasker JJ. Rheumatologists and their patients who seek alternative care: an agreement to disagree. Br J Rheumatol 1992;31:485-90.
42. MacGregor FB, Abernethy VE, Dahahra S, Cobden I, Hayes PC. Hepatotoxicity of hcrhal remedies. BMJ 1989;299:1156-7.
43. Gertner E, Marshall PS, Filandrinos D, Potek AS, Smith TM. Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs. Arthritis Rheum 1995;38:614-7.
44. DiPaola RS, Zhang H, Lambert GH, Meeker R, Licitra E, Rafi MM, et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 1998; 339:785-91.
45. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340:1733-9.
46. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Boston: Nimrod Press; 1993.
47. Vecchio PC. Attitudes to alternative medicine by rheumatology outpatient attenders. J Rheumatol 1994;21:145-7.
48. Ramsey C, Walker M, Alexander J. Alternative medicine in Canada: use and public attitudes. Public Policy Sources. No. 21. Vancouver, BC, Canada: The Fraser Institute; 1999.